ClinicalTrials.Veeva

Menu

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

W

Warner Chilcott

Status and phase

Terminated
Phase 2

Conditions

Erectile Dysfunction

Treatments

Drug: WC3036-12F/Alprostadil in Vehicle 0.5%
Drug: WC3036-13P/Vehicle Only 0.5%
Drug: WC3036-11F/Alprostadil in Vehicle 2.5%

Study type

Interventional

Funder types

Industry

Identifiers

NCT01810575
PR-13311

Details and patient eligibility

About

The purpose of this study is to assess the safety & efficacy of a single dose of alprostadil cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile dysfunction.

Enrollment

16 patients

Sex

Male

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male subject aged 40 or older of any race
  • History of ED (erectile dysfunction) of at least 3 months duration defined as inability to attain & maintain an erection of the penis sufficient to permit satisfactory sexual intercourse
  • Completed and signed informed consent prior to any study related procedures

Exclusion criteria

  • History/presence any significant disease that Investigator feels will interfere with course of the study
  • Anatomic deformity of penis
  • History/presence alcoholism or drug abuse/dependence within past 2 years (discretion of Investigator)
  • Participation in investigational study drug trial within 30 days prior to randomization

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

16 participants in 3 patient groups, including a placebo group

WC3036-11F/Alprostadil in Vehicle 2.5%
Active Comparator group
Description:
Treatment A
Treatment:
Drug: WC3036-11F/Alprostadil in Vehicle 2.5%
WC3036-12F/Alprostadil in Vehicle 0.5%
Experimental group
Description:
Treatment B
Treatment:
Drug: WC3036-12F/Alprostadil in Vehicle 0.5%
WC3036-13P/Vehicle Only 0.5%
Placebo Comparator group
Description:
Treatment C
Treatment:
Drug: WC3036-13P/Vehicle Only 0.5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems